CureZone   Log On   Join
Regorafenib: An Oral Multi-kinase Inhibitor

Clarkia Extra Strong
Clarkia Tincture 2 oz, 4 oz, 8 oz, and 16 oz

Natural Cancer Remedies
Hundreds of thousands have cured their own cancers, and now yo...

marykudro Views: 108
Published: 35 days ago

Regorafenib: An Oral Multi-kinase Inhibitor

Regorafenib is introduced under the brand name Stivarga. It is mainly an oral multi-kinase inhibitor that targets angiogenic, stromal, and oncogenic RTK. The medical approval of regorafenib includes Metastatic colorectal cancer, Advanced gastrointestinal stromal tumors, and advanced hepatocellular carcinoma. Regorafenib represents the anti-angiogenic activity because of its dual-targeted VEGFR2-TIE2 tyrosine kinase inhibition. This drug is being approved with a Boxed Warning alerting patients and health specialists that fatal liver toxicity may occur in recipients treated with regorafenib during clinical studies.


Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


Donate to CureZone

CureZone Newsletter is distributed in partnership with

Contact Us - Advertise - Stats

Copyright 1999 - 2021

1.500 sec, (1)